MESSAGE FROM THE ACADEMIC DIRECTOR
I am pleased to share our Kolling Institute newsletter, profiling the very latest research progress, and the dynamic teams driving improvements in care. This edition highlights a number of exciting clinical trials, a collection of high-profile recognition awards, and crucial developments with our cancer research. It’s a chance to learn more about our current investigations, and the large number of dedicated clinicians and researchers extending our access to high- quality care. Research Strategy news Encouraging progress has been made with the development of the 2026-2031 Kolling Institute Research Strategy. This strategic framework will have a significant impact on the future direction of the Kolling, the focus of resources and the institute’s research success. A large part of the progress is due to the Kolling Steering Committee, where members have been meeting regularly ahead of wider consultation with the research community. I would like to express my thanks for their expert help and for their valuable time helping to develop the next strategy. It aims to provide a comprehensive plan to strengthen community impact through discovery, innovation and implementation, and to work towards a future where communities thrive as a result of medical and scientific breakthroughs.
Steering committee discussions have centred on a review of the current strategy, the effectiveness of the three-priority research area approach, and what areas need to be enhanced. Discussions have also focused on extending collaborations and increasing sustainability. Further meetings and consultation will be held throughout the year to finalise the strategic blueprint, ahead of its launch in early 2026. Key performance report card We recently received data confirming our key performance indicators are tracking well. Researchers secured $12.6 million in highly-competitive grant funding last year, and this may rise with the outcome of a large number of grants still pending. The figures confirm our category 1 funding, in particular, is well above the national average. Importantly, we are strengthening our international partnerships, with our researchers collaborating on publications with investigators from 130 countries in 2024. This represents a 60 per cent increase since 2021, and includes researchers research activity is expanding with 629 papers published last year, up from 576 in 2023. It is wonderful to see consistent growth in this area, clearly demonstrating the commitment to high quality, peer-reviewed journals. from right across the world. I am pleased to report our
A word of thanks for Professor Baxter I would like to thank Professor Nancy Baxter for her generous contributions and support of the Kolling Institute during her time as Interim Deputy Executive Dean (Research Centres) in the Faculty of Medicine and Health at the University of Sydney. Endocrinologist and senior leader Professor John Prins has now joined the university as the Executive Dean of the Faculty of Medicine and Health, and we look forward to welcoming him as a member of the Kolling Institute Governance Committee. Kolling Symposium It may be a couple of months away, but preparations are in full swing for this year’s Kolling Symposium. The event will be held in the Kolling auditorium on Thursday November 27th. This year’s theme, Discovery and Implementation through Collaboration, highlights the potential of shared ideas to drive improvements in care. We are pleased to announce award- winning broadcast journalist Sophie Scott will be our keynote speaker this year, discussing how to tap into your expertise for thought leadership. Registrations are now open.
http://bit.ly/4gwbFCp Professor James Elliott
2
KOLLINGNEWS | SEPTEMBER 2025
Made with FlippingBook - professional solution for displaying marketing and sales documents online